Walpar Nutritions Ltd
Incorporated in 2009, Walpar Nutritions Ltd manufactures and trades Pharmaceutical, Nutraceutical, Herbal and Ayurvedic commodities[1]
- Market Cap ₹ 55.9 Cr.
- Current Price ₹ 119
- High / Low ₹ 154 / 78.0
- Stock P/E 52.8
- Book Value ₹ 28.4
- Dividend Yield 0.00 %
- ROCE 11.6 %
- ROE 8.60 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Debtor days have improved from 103 to 71.8 days.
- Company's working capital requirements have reduced from 91.3 days to 48.6 days
Cons
- Stock is trading at 4.19 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.67% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1.43 | 6.07 | 26.76 | 28.70 | 51.31 | |
| 1.05 | 5.61 | 25.68 | 27.92 | 49.54 | |
| Operating Profit | 0.38 | 0.46 | 1.08 | 0.78 | 1.77 |
| OPM % | 26.57% | 7.58% | 4.04% | 2.72% | 3.45% |
| 0.00 | 0.00 | 0.02 | 0.27 | 0.13 | |
| Interest | 0.05 | 0.18 | 0.48 | 0.34 | 0.21 |
| Depreciation | 0.02 | 0.12 | 0.28 | 0.25 | 0.21 |
| Profit before tax | 0.31 | 0.16 | 0.34 | 0.46 | 1.48 |
| Tax % | 25.81% | 6.25% | -26.47% | 34.78% | 24.32% |
| 0.23 | 0.15 | 0.42 | 0.29 | 1.11 | |
| EPS in Rs | 0.77 | 0.45 | 0.92 | 0.64 | 2.36 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 104% |
| TTM: | 79% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 92% |
| TTM: | 266% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 51% |
| 1 Year: | 44% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.34 | 4.54 | 4.54 | 4.70 |
| Reserves | 0.23 | 1.44 | 6.49 | 6.78 | 8.64 |
| 5.88 | 5.46 | 4.38 | 3.21 | 0.32 | |
| 5.44 | 5.45 | 7.95 | 7.33 | 9.84 | |
| Total Liabilities | 14.55 | 15.69 | 23.36 | 21.86 | 23.50 |
| 1.15 | 1.07 | 0.94 | 0.83 | 1.48 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Investments | 0.00 | 0.06 | 2.93 | 2.84 | 4.70 |
| 13.40 | 14.56 | 19.49 | 18.17 | 17.30 | |
| Total Assets | 14.55 | 15.69 | 23.36 | 21.86 | 23.50 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 0.40 | 1.38 | -0.32 | 1.09 | 3.13 | |
| 0.00 | -0.70 | -4.58 | 0.46 | -0.88 | |
| -0.24 | -0.06 | 4.27 | -1.52 | -2.18 | |
| Net Cash Flow | 0.17 | 0.62 | -0.63 | 0.03 | 0.07 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Dec 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 2,141.50 | 430.54 | 124.26 | 111.66 | 71.78 |
| Inventory Days | 1,690.75 | 369.26 | 103.22 | 89.87 | 39.99 |
| Days Payable | 2,156.44 | 434.08 | 130.02 | 99.69 | 67.10 |
| Cash Conversion Cycle | 1,675.81 | 365.73 | 97.45 | 101.84 | 44.67 |
| Working Capital Days | 1,556.99 | 439.56 | 117.71 | 107.72 | 48.59 |
| ROCE % | 6.55% | 5.34% | 11.56% |
Documents
Announcements
-
Updates
9 July 2024 - Walpar Nutritions Limited has informed regarding 'Non-applicability of Corporate Governance Provisions as per SEBI (LODR) Regulation, 2015'.
-
Updates
9 July 2024 - Walpar Nutritions Limited has informed regarding 'Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation, 2018 for the Quarter ended on 30th …
-
Notice Of Shareholders Meetings-XBRL
8 July 2024 - WALPAR NUTRITIONS LIMITED has informed about Notice of Shareholders Meeting for Annual General Meeting to be held on 30-Jul-2024
-
Book Closure
8 July 2024 - Register of Members & Share Transfer Books of the Company will remain closed from 23-Jul-2024 to 30-Jul-2024 for the purpose of Meeting.
-
Shareholders meeting
8 July 2024 - Walpar Nutritions Limited has informed regarding Notice of Annual General Meeting to be held on July 30, 2024
Business Overview:[1]
Company manufactures and sells Nutraceutical and Herbal dietary supplement formulations, ingredients and research. It manufactures private label brands for different companies and its own brands, selling through online and direct channels. Company is a specialized Contract manufacturer for different formulation in Nutraceuticals and Herbal products